Baidu, Inc. (NASDAQ:BIDU – Get Free Report) has earned an average rating of “Hold” from the nineteen brokerages that are presently covering the stock, Marketbeat reports. Twelve investment analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $111.25.
Several equities analysts recently weighed in on BIDU shares. Nomura Securities lowered Baidu from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Mizuho boosted their price objective on Baidu from $95.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, February 19th. StockNews.com lowered Baidu from a “buy” rating to a “hold” rating in a research report on Wednesday, February 19th. Nomura lowered shares of Baidu from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Baidu in a report on Saturday, March 8th.
View Our Latest Research Report on BIDU
Hedge Funds Weigh In On Baidu
Baidu Stock Down 5.1 %
BIDU stock opened at $93.37 on Tuesday. The firm’s fifty day moving average is $91.61 and its 200 day moving average is $90.39. The firm has a market cap of $32.74 billion, a PE ratio of 10.18, a P/E/G ratio of 2.96 and a beta of 0.47. Baidu has a one year low of $77.20 and a one year high of $116.25. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.19 and a current ratio of 2.09.
About Baidu
Baidu, Inc engages in the provision of internet search services in China. It operates through two segments: Baidu Core and iQIYI. The company offers Baidu App to access search, feed, and other services using mobile devices; Baidu Search to access its search and other services; Baidu Feed that provides users with personalized timeline based on their demographics and interests; Baidu Health that helps users to find the doctor and hospital for healthcare needs; and Haokan, a short video app.
See Also
- Five stocks we like better than Baidu
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- MarketBeat Week in Review – 03/24 – 03/28
- How to Buy Gold Stock and Invest in Gold
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Baidu Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baidu and related companies with MarketBeat.com's FREE daily email newsletter.